AAAAAA

   
Results: 1-13 |
Results: 13
FRENCH PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA-A AFTER EXPOSURE TO RECOMBINANT FACTOR-VIII - INCIDENCE OF INHIBITOR AND EVALUATION OF IMMUNE TOLERANCE
Authors: ROTHSCHILD C LAURIAN Y SATRE EP DERLON AB CHAMBOST H MOREAU P GOUDEMAND J PARQUET A PEYNET J VICARIOT M BEURRIER P CLAEYSSENS S DURIN A FARADJI A FRESSINAUD E GAILLARD S GUERIN V GUEROIS C PERNOD G POUZOL P SCHVED JF GAZENGEL C
Citation: C. Rothschild et al., FRENCH PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA-A AFTER EXPOSURE TO RECOMBINANT FACTOR-VIII - INCIDENCE OF INHIBITOR AND EVALUATION OF IMMUNE TOLERANCE, Thrombosis and haemostasis, 80(5), 1998, pp. 779-783
HOME TREATMENT WITH RECOMBINANT FACTOR VIIA (RFVIIA) IN HEMOPHILIA-A OR HEMOPHILIA-B PATIENTS WITH INHIBITORS
Authors: LAURIAN Y GOUDEMAND J NEGRIER C VICARIOT M MARQUESVERDIER A FONLUPT J GAILLARD S FRESSINAUD E DIRAT G SULTAN Y FARADJI A CLAYESSENS S GUEROIS C PEYNET J BERTRAND MA DIGY JP
Citation: Y. Laurian et al., HOME TREATMENT WITH RECOMBINANT FACTOR VIIA (RFVIIA) IN HEMOPHILIA-A OR HEMOPHILIA-B PATIENTS WITH INHIBITORS, British Journal of Haematology, 102(1), 1998, pp. 15-15
ASSESSMENT OF TRANSFUSION PRACTICE - SURV EYS IN 4 HOSPITALS FOR ASSESSING NURSES CARE IN TRANSFUSION MEDICINE
Authors: FRUCHART MF PAUCHETTRAVERSAT AF FIALON P GARROUSTE D KLAREN J FARADJI A WALLER C
Citation: Mf. Fruchart et al., ASSESSMENT OF TRANSFUSION PRACTICE - SURV EYS IN 4 HOSPITALS FOR ASSESSING NURSES CARE IN TRANSFUSION MEDICINE, Transfusion clinique et biologique, 4(5), 1997, pp. 501-507
USE OF NOVOSEVEN(R) AS FIRST LINE THERAPY FOR BLEEDING EPISODES IN HEMOPHILIACS WITH FACTOR-VIII OR FACTOR-IX INHIBITORS (NOSEPAC STUDY)
Authors: LAURIAN Y GOUDEMAND J NEGRIER C VICARIOT M MARQUESVERDIER A FONLUPT J GAILLARD S FRESSINAUD E DIRAT G SULTAN Y FARADJI A CLAYESSENS S GUEROIS C PEYNET J BERTRAND MA
Citation: Y. Laurian et al., USE OF NOVOSEVEN(R) AS FIRST LINE THERAPY FOR BLEEDING EPISODES IN HEMOPHILIACS WITH FACTOR-VIII OR FACTOR-IX INHIBITORS (NOSEPAC STUDY), Thrombosis and haemostasis, 1997, pp. 342-342
INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A RECEIVING RECOMBINANT FACTOR (RFVIII)
Authors: ROTHSCHILD C LAURIAN Y SATRE EP BORELDERLON A CHAMBOST H MOREAU P GOUDEMAND J PARQUET A VICARIOT M BEURRIER P CLAEYSSENS S DURIN A FARADJI A FRESSINAUD E GAILLARD S GUERIN V GUEROIS C PERNOD G PEYNET J POUZOL P SCHVED JF GAZENGEL C
Citation: C. Rothschild et al., INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A RECEIVING RECOMBINANT FACTOR (RFVIII), Thrombosis and haemostasis, 1997, pp. 2654-2654
PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF PERIPHERAL-BLOOD STEM-CELLS MOBILIZED EITHER WITH G-CSF OR G-CSF PLUS STEM-CELL FACTOR IN MYELOMA PATIENTS
Authors: BOHBOT A MALOISEL F ALLAM A KARCHER V FARADJI A OBERLING F LIOURE B
Citation: A. Bohbot et al., PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF PERIPHERAL-BLOOD STEM-CELLS MOBILIZED EITHER WITH G-CSF OR G-CSF PLUS STEM-CELL FACTOR IN MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 4200-4200
USE OF NOVOSEVEN(TM) AS FIRST LINE THERAPY FOR BLEEDING EPISODES IN HEMOPHILIACS WITH FACTOR-VIII OR FACTOR-IX INHIBITORS (NOSEPAC STUDY)
Authors: LAURIAN Y GOUDEMAND J NEGRIER C VICARIOT M MARQUESVERDIER A FONLUPT J GAILLARD S FRESSINAUD E DIRAT G SULTAN Y FARADJI A CLAYESSENS S GUEROIS C PEYNET J BERTRAND MA
Citation: Y. Laurian et al., USE OF NOVOSEVEN(TM) AS FIRST LINE THERAPY FOR BLEEDING EPISODES IN HEMOPHILIACS WITH FACTOR-VIII OR FACTOR-IX INHIBITORS (NOSEPAC STUDY), Blood, 90(10), 1997, pp. 150-150
CD34 CELL SELECTION FROM CRYOPRESERVED PERIPHERAL-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS
Authors: BOHBOT A LIOURE B FARADJI A ALLAM A LAPLACE A OBERLING F
Citation: A. Bohbot et al., CD34 CELL SELECTION FROM CRYOPRESERVED PERIPHERAL-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS, Experimental hematology, 24(9), 1996, pp. 137-137
POSITIVE SELECTION OF CD34(-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS AND CLINICAL USE() CELLS FROM CRYOPRESERVED PERIPHERAL)
Authors: BOHBOT A LIOURE B FARADJI A SCHMITT M CUILLEROT JM LAPLACE A OBERLING F
Citation: A. Bohbot et al., POSITIVE SELECTION OF CD34(-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS AND CLINICAL USE() CELLS FROM CRYOPRESERVED PERIPHERAL), Bone marrow transplantation, 17(2), 1996, pp. 259-264
FIRST CASE OF CONGENITAL PORPHYRIA TREATE D BY CORD-BLOOD STEM-CELL TRANSPLANTATION, IN STRASBOURG (FRANCE)
Authors: LANGER B KIEFFER I BABINBOILLETOT A BOHBOT A FARADJI A OBERLING F SCHLAEDER G GEISERT J LEVY JM LUTZ P
Citation: B. Langer et al., FIRST CASE OF CONGENITAL PORPHYRIA TREATE D BY CORD-BLOOD STEM-CELL TRANSPLANTATION, IN STRASBOURG (FRANCE), La Semaine des hopitaux de Paris, 72(9-10), 1996, pp. 312-312
PERIPHERAL-BLOOD CD34- METHOD OF PURIFICATION AND EX-VIVO EXPANSION( CELLS )
Authors: BOHBOT A FEUGEAS O CUILLEROT JM GROSSE A RUSCIANI I FARADJI A OBERLING F
Citation: A. Bohbot et al., PERIPHERAL-BLOOD CD34- METHOD OF PURIFICATION AND EX-VIVO EXPANSION( CELLS ), Nouvelle revue francaise d'hematologie, 37(6), 1995, pp. 359-365
CD34- EX-VIVO EXPANSION AND CYTOADHESION MOLECULES EXPRESSION( CELLS )
Authors: BOHBOT A FARADJI A FEUGEAS O CUILLEROT JM GROSSE A RUSCIANI I OBERLING F
Citation: A. Bohbot et al., CD34- EX-VIVO EXPANSION AND CYTOADHESION MOLECULES EXPRESSION( CELLS ), Experimental hematology, 22(8), 1994, pp. 758-758
LARGE-SCALE ISOLATION OF HUMAN BLOOD MONOCYTES BY CONTINUOUS-FLOW CENTRIFUGATION LEUKAPHERESIS AND COUNTERFLOW CENTRIFUGATION ELUTRIATION FOR ADOPTIVE CELLULAR IMMUNOTHERAPY IN CANCER-PATIENTS
Authors: FARADJI A BOHBOT A SCHMITTGOGUEL M SIFFERT JC DUMONT S WIESEL ML PIEMONT Y EISCHEN A BERGERAT JP BARTHOLEYNS J POINDRON P WITZ JP OBERLING F
Citation: A. Faradji et al., LARGE-SCALE ISOLATION OF HUMAN BLOOD MONOCYTES BY CONTINUOUS-FLOW CENTRIFUGATION LEUKAPHERESIS AND COUNTERFLOW CENTRIFUGATION ELUTRIATION FOR ADOPTIVE CELLULAR IMMUNOTHERAPY IN CANCER-PATIENTS, Journal of immunological methods, 174(1-2), 1994, pp. 297-309
Risultati: 1-13 |